Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Steroid 5 alpha-reductase is a family of membrane-bound enzymes that catalyze the irreversible reduction of the Δ4,5 double bond in Δ4-3-ketosteroids, converting testosterone into dihydrotestosterone (DHT). There are three main isozymes: Type 1 (SRD5A1), Type 2 (SRD5A2), and Type 3 (SRD5A3). Type 2 is especially important for male sexual development. Inhibitors like finasteride and dutasteride are used for BPH, androgenetic alopecia, and sometimes prostate cancer. Mutations can cause disorders of sex development.
Inhibition of steroid 5 alpha-reductase activity, reducing DHT levels
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Steroid 5 alpha-reductase (5α-reductase).